Cytokines in preterm delivery

Laboratory Medicine

Volumn 43, Issue 4, 2012, Pages 27-30

  Arababadi, Mohammad Kazemi ^a,b   Aminzadeh, Fariba ^a   Hassanshahi, Gholamhossein ^a,b   Khorramdelazad, Hossein ^b   Norouzi, Mojgan ^b   Zarandi, Ebrahim Rezazadeh ^a   Rezayati, Mohammadtaghi ^a   Kennedy, Derek ^c  

^a Faculty of Medicine   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

IL 10; IL 12; IL 6; Pregnancy; Preterm delivery

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOTHER; NEWBORN; PREMATURE LABOR; PROGNOSIS; PROTEIN BLOOD LEVEL; UMBILICAL CORD BLOOD;

EID: 84869487200     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMY9ILPGSETU2CO0     Document Type: Article

References (42)

1. Mazur E, Wolski A. Cytokines: Regulations of immune response during infection [in Polish]. Pol Merkur Lekarski. 2001;11:375-377.
2. Zwirner NW, Domaica CI. Cytokine regulation of natural killer cell effector functions. Biofactors. 2010;36:274-288.
3. Miyazono K, Suzuki H, Imamura T. Regulation of TGF-⊗ signaling and its roles in progression of tumors. Cancer Sci. 2003;94:230-234.
4. Dooms H, Abbas AK. Revisiting the role of IL-2 in autoimmunity. Eur J Immunol. 2010;40:1538-1540.
5. Vallochi AL, Commodaro AG, Schwartzman JP, et al. The role of cytokines in the regulation of ocular autoimmune inflammation. Cytokine Growth Factor Rev. 2007;18:135-141.
6. McEwan M, Lins RJ, Munro SK, et al. Cytokine regulation during the formation of the fetal-maternal interface: Focus on cell-cell adhesion and remodelling of the extra-cellular matrix. Cytokine Growth Factor Rev. 2009;20:241-249.
7. Gotsch F, Romero R, Friel L, et al. CXCL10/IP-10: A missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med. 2007;20:777-792.
8. Wegmann TG, Lin H, Guilbert L, et al. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353-356.
9. Hunt JS, Miller L, Roby KF, et al. Female steroid hormones regulate production of pro-inflammatory molecules in uterine leukocytes. J Reprod Immunol. 1997;35:87-99.
10. Forbes K, Westwood M. Maternal growth factor regulation of human placental development and fetal growth. J Endocrinol. 2010;207:1-16.
11. Zarnani AH, Moazzeni SM, Shokri F, et al. Microenvironment of the feto-maternal interface protects the semiallogenic fetus through its immunomodulatory activity on dendritic cells. Fertil Steril. 2008;90:781-788.
12. Southcombe J, Redman C, Sargent I. Peripheral blood invariant natural killer T cells throughout pregnancy and in preeclamptic women. J Reprod Immunol. 2010;87:52-59.
13. Martínez-García EA, Sánchez-Hernández PE, Chavez-Robles B, et al. The distribution of CD56(dim) CD16+ and CD56(bright) CD16-cells are associated with prolactin levels during pregnancy and menstrual cycle in healthy women. Am J Reprod Immunol. 2011;65:433-437.
14. Triche EW, Hossain N, Paidas MJ. Genetic influences on smoking cessation and relapse in pregnant women. J Obstet Gynaecol. 2008;28:155-160.
15. Garland SM, Ní Chuileannáin F, Satzke C, et al. Mechanisms, organisms and markers of infection in pregnancy. J Reprod Immunol. 2002;57:169-183.
16. Haimovici F, Anderson DJ. Effects of growth factors and growth factor-extracellular matrix interactions on mouse trophoblast outgrowth in vitro. Biol Reprod. 1993;49:124-130.
17. Watford WT, Moriguchi M, Morinobu A, et al. The biology of IL-12: Coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003;14:361-368.
18. Bachmayer N, Rafik Hamad R, Liszka L, et al. Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol. 2006;56:292-301.
19. Del Vecchio M, Bajetta E, Canova S, et al. Interleukin-12: Biological properties and clinical application. Clin Cancer Res. 2007;13:4677-4685.
20. Wang C, Tanaka T, Nakamura H, et al. Granulated metrial gland cells in the murine uterus: Localization, kinetics, and the functional role in angiogenesis during pregnancy. Microsc Res Tech. 2003;60:420-429.
21. Thaxton JE, Sharma S. Interleukin-10: A multi-faceted agent of pregnancy. Am J Reprod Immunol. 2010;63:482-491.
22. Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: A systematic review. Obstet Gynecol. 2010;116(2, Pt 1):393-401.
23. Bakheit KH, Bayoumi NK, Adam I. Peripheral, placental and cord cytokines profile in spontaneous labor and elective caesarean section. Iran J Immunol. 2008;5:185-188.
24. Fukuda H, Masuzaki H, Ishimaru T. Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with pre-term, premature rupture of the membranes. Int J Gynaecol Obstet. 2002;77:123-129.
25. Yang Q, El-Sayed Y, Rosenberg-Hasson Y, et al. Multiple cytokine profile in plasma and amniotic fluid in a mouse model of pre-term labor. Am J Reprod Immunol. 2009;62:339-347.
26. Lockwood CJ, Murk WK, Kayisli UA, et al. Regulation of interleukin-6 expression in human decidual cells and its potential role in chorioamnionitis. Am J Pathol. 2010;177:1755-1764.
27. Skogstrand K, Hougaard DM, Schendel DE, et al. Association of preterm birth with sustained postnatal inflammatory response. Obstet Gynecol. 2008;111:1118-1128.
28. Jarocki S, Redźko S, Przepieść J, et al. Maternal serum Th1 and Th2 cytokines in preterm and term delivery [in Polish]. Ginekol Pol. 2007;78:284-287.
29. Sorokin Y, Romero R, Mele L, et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth < 32 weeks and adverse neonatal outcomes. Am J Perinatol. 2010;27:631-640.
30. Torbé A, Czajka R, Kordek A, et al. Maternal serum proinflammatory cytokines in preterm labor with intact membranes: Neonatal outcome and histological associations. Eur Cytokine Netw. 2007;18:102-107.
31. Škrablin S, Lovrić H, Banović V, et al. Maternal plasma interleukin-6, interleukin-1β and C-reactive protein as indicators of tocolysis failure and neonatal outcome after preterm delivery. J Matern Fetal Neonatal Med. 2007;20:335-341.
32. McElrath TF, Fichorova RN, Allred EN, et al. Blood protein profiles of infants born before 28 weeks differ by pregnancy complication. Am J Obstet Gynecol. 2011;204:418.
33. Andrys C, Drahosova M, Hornychova H, et al. Umbilical cord blood concentrations of IL-6, IL-8, and MMP-8 in pregnancy complicated by preterm premature rupture of the membranes and histological chorioamnionitis. Neuro Endocrinol Lett. 2010;31:857-863.
34. Vega-Sanchez R, Barajas-Vega HA, Rozada G, et al. Association between adiposity and inflammatory markers in maternal and fetal blood in a group of Mexican pregnant women. Br J Nutr. 2010;104:1735-1739.
35. Genc MR, Ford CE. The clinical use of inflammatory markers during pregnancy. Curr Opin Obstet Gynecol. 2010;22:116-121.
36. Dubicke A, Fransson E, Centini G, et al. Pro-inflammatory and anti-inflammatory cytokines in human preterm and term cervical ripening. J Reprod Immunol. 2010;84:176-185.
37. El-Shazly S, Makhseed M, Azizieh F, et al. Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. Am J Reprod Immunol. 2004;52:45-52.
38. Lemancewicz A, Urban R, Urban J, et al. Evaluation of interleukin concentrations in amniotic fluid in preterm and term parturition and in oligohydramnios. Med Sci Monit. 2001;7:924-927.
39. Ekelund CK, Vogel I, Skogstrand K, et al. Interleukin-18 and interleukin-12 in maternal serum and spontaneous preterm delivery. J Reprod Immunol. 2008;77:179-185.
40. Matoba N, Yu Y, Mestan K, et al. Differential patterns of 27 cord blood immune biomarkers across gestational age. Pediatrics. 2009;123:1320-1328.
41. Blanco-Quirós A, Arranz E, Solis G, et al. Cord blood interleukin-10 levels are increased in preterm newborns. Eur J Pediatr. 2000;159:420-423.
42. Hodges R, Salvador L, D'Antona D, et al. Activin A as a marker of intrauterine infection in women with preterm prelabour rupture of membranes. J Perinatol. 2010;30:22-26.